Fri Feb 25, 2022 – 6:15 pm EST
(LifeSiteNews) – A large German health insurer has raised concerns over what its data shows to be an excessive underreporting by government authorities of adverse events after experimental COVID-19 gene-based vaccine injections.
Andreas Schöfbeck, a board member of BKK ProVita, addressed the company’s findings in a formal letter to the government’s Paul Ehrlich Institute (PEI), which had reported earlier this year that there were 244,576 suspected cases of side effects from the gene-based injections in the calendar year 2021.
Speaking to this figure, Schöfbeck wrote, “The data available to our company gives us reason to believe that there is a very considerable under-recording of suspected cases of vaccination side effects after [patients] received the [COVID-19] vaccine.”
Explaining that their sample includes 10,937,716 insured clients, with available data covering only the first 7½ months of 2021, their company had already logged 216,695 cases of adverse reactions for COVID-19 gene-based injections.
Extending this rate for the full year, and then applying it to the full population of Germany (around 83 million), one can estimate that likely 2.5 million to 3 million individuals in the nation were treated by medical professionals for such adverse
The remainder of this article is available in its entirety at LifeSite News
The views expressed in this news alert by the author do not directly represent that of The Official Street Preachers or its editors
